Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 15,235

Document Document Title
WO/2016/191872A1
Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Also...  
WO/2016/193220A1
The present invention relates to a method for changing the pigmentation of a skin, a mucous membrane or hair with a compound of general formula (I), a cosmetic use of said compound of general formula (I), to cosmetic compositions compris...  
WO/2016/192829A1
The present invention relates to feed media comprising deep eutectic solvents and/or ionic liquids.  
WO/2016/192830A1
The present invention relates to cell culture media compositions comprising deep eutectic solvents and/or ionic liquids.  
WO/2016/192631A1
The present invention provides an abietane-type diterpene compound having lipid-lowering activity, a method for preparing same, and use of same. Specifically, the compound has the structure shown in formula I. The definitions of the grou...  
WO/2016/189877A1
The present invention provides a urea compound or a pharmacologically acceptable salt thereof that has a formyl peptide receptor like 1 (hereinafter may be abbreviated as FPRL1) agonist effect, a pharmaceutical composition containing the...  
WO/2016/168670A3
The present disclosure relates to methods of extending the lifespan of a subject or treating, suppressing, inhibiting or delaying the onset of an age-related condition or disorder, such as cancer, in a subject. The methods comprise admin...  
WO/2016/187722A1
Ocular compositions comprising a CB2 target agent and a cannabimimetic agent that is a non-selective cannabinoid receptor agent are useful in the treatment of ocular inflammation and ocular neuropathic pain. The CB2 target agent may be a...  
WO/2016/188945A1
The present invention relates to the field of separating chiral isomers from each other. Particularly, it relates to the field of separating of chiral isomers of chromane or chromene compounds, particularly tocopherols, 3,4-dehydro-tocop...  
WO/2016/126423A3
Z is CR4R5, C=CR4R5 SiR4R5, GeR4R5 NR4a, PR4a, P(O)R4a, O, S, SO, SO2, Se; SeO, SeO2, Te, TeO, or TeO2; R1 - R3 are the same or different at each occurrence and are D, aryl, heteroaryl, alkyl, amino, silyl, germyl, deuterated aryl, deute...  
WO/2016/190852A1
Disclosed herein are methods and compositions for the treatment and/or prevention of diseases or conditions comprising administration of chromanyl compounds, and/or naturally or artificially occurring derivatives, analogues, stereoisomer...  
WO/2016/183809A1
The present invention relates to a nebivolol synthesis method and intermediate compound thereof. Specifically, the present invention relates to a method for synthesizing nebivolol, intermediate compound thereof and method for preparing t...  
WO/2016/183157A1
Isoflavonoids or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof for the treatment of prostate cancer or for the treatment or inhibition of prostate cancer metastasis in a patient in need the...  
WO/2016/183185A1
Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): including stereoisomers, salts and tautomers thereof, wherein R1, R2, R3, R4, R5, L1, L2, L3, L4, M, m and n are as defined he...  
WO/2016/179645A1
The present disclosure relates to 4H-pyran compounds of formula (I) and their use in therapy, to compositions and agents comprising said compounds, to methods of treatment using said compounds, and their use in the manufacture of medicam...  
WO/2016/183315A1
A glutathione-cleavable prodrug is provided herein, as well as methods for its use in treating cancer, including triple negative breast cancer. The prodrug can be cleaved by glutathione under physiological conditions to generate a biolog...  
WO/2016/100576A9
The invention relates to methods of separating Trolox isomers (R)-Trolox and (S)-Trolox, comprising: (a) contacting a mixture of (R) and (S)-Trolox with a resolving agent selected from the group consisting of (1S,2S)-(+)-Pseudoephedrine,...  
WO/2016/174226A1
The present invention relates to compounds of general formula (I), wherein R1-R8 take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of cancer.  
WO/2016/166623A1
A system for collecting cannabis and the psychoactive component tetrahydrocannabinol from a sample of exhaled breath is disclosed. Single or multiple exhaled breaths are conditioned by removing contaminants, and regulating flow rate and/...  
WO/2016/158169A1
The present invention is a compound represented by general formula (1).  
WO/2016/158168A1
This resist composition contains one or more components selected from among compounds represented by a specified formula, and resins obtained using the compounds as monomers.  
WO/2016/154705A1
The invention provides in part dhilirolide compounds for insect control, for such insects as Trichoplusia ni, and methods thereof. The compounds include compounds of Formula I.  
WO/2016/061555A3
The invention relates to methods of treating cell proliferative disorders. The invention further relates to pharmaceutical compositions for treating cell proliferative disorders, especially cancer.  
WO/2016/159021A1
[Problem] To provide a novel compound. [Solution] A compound represented by formula (I) or formula (II), a salt thereof, or a solvate thereof. R1 represents a hydrogen atom or a halogen atom; each of R2-R4 represents a hydrogen atom, a h...  
WO/2016/151484A1
This invention relates to new inhibitors of butyrylcholinesterase with general formulas I and II, where substituents are described in patent description. Compounds can be in the form of pure enantiomers or as racemic mixtures, or in the ...  
WO/2016/153432A1
The present invention relates to substituted phenyl cinnamyl ketones of Formula (I) for use in therapy: wherein R1 to R11 are defined as described in the specification, or a pharmaceutically acceptable salt, tautomer(s), solvate or polym...  
WO/2016/150025A1
A method for preparing high-content mixed tocopherols through lyotropic liquid crystal extraction and separation, comprising the following steps: dissolving vegetable oil deodorized distillate which is esterified or is subjected to fatty...  
WO/2016/153167A1
The present invention relates to an isolation method for chrysoeriol using a planthopper. When using the method for isolating chrysoeriol from a rice plant inoculated with a planthopper according to the present invention, not only it is ...  
WO/2016/154545A1
The present inventor has discovered how to adsorb a mitochondrially targeted compound (MTC) of general formula I on contact lenses and other matrices prior the application of lenses or other matrix on the eye surface. After such matrix i...  
WO/2016/151295A1
The present invention relates to a process for producing an organic compound comprising an 18F atom, which process comprises treating a precursor organic compound comprising a –CY2X group with: (i) [18F] fluoride; and (ii) an activator...  
WO/2016/147356A1
Provided are: an aromatic sulfonium salt compound that exhibits low corrosion with respect to a substrate, that has excellent photolithographic characteristics, and that is useful in a photoacid generator and a cationic polymerization ag...  
WO/2016/149471A1
Novel fluorophores and their use as fluorescent tags for polymers used in wastewater treatment. The fluorophores are quaternary amine salts that can be used to synthesize fluorescent tagged polymers that are stable at varying pH, have si...  
WO/2016/144637A1
A compound including an ester of tocopheryloxyacetic acid with an anticancer or antirestenotic agent selected from the group consisting of SN38, paclitaxel, camptothecin, 7-ethylcamptothecin, etoposide, fenretinide, and lestaurtinib. If ...  
WO/2016/135346A1
The invention relates to cannabinoids, to the isolation and purification of same, as well as to obtaining these by means of centrifugal partition chromatography, a solvent being selected from the group consisting of cyclohexane, heptane,...  
WO/2016/115263A8
The present disclosure provides edible compositions comprising a sweet taste modulator or bitter taste blocker of the present disclosure, food products comprising such edible compositions and methods of preparing such food products. The ...  
WO/2016/131098A1
ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in ...  
WO/2016/127873A1
The present invention provides an isothiocyanate compound and an application thereof. The compound is an aryl substituted isothiocyanate compound that has a structure in the general formula I. The isothiocyanate compound in the present i...  
WO/2016/129983A1
The present invention relates to novel N-acyl-diarysulfonamides acting as inhibitors of bacterial aminoacyl-tRNA synthetase. These can be used as medicines or as constituent of medicines for the treatment of bacterial infections.  
WO/2016/130086A1
The present invention relates to the synthesis and characterization of an Abcg2 targeted fluorescence probe (compound of formula I), as well as live imaging of neural stem/progenitor cells (NSPCs) and isolation of live NSPCs using said p...  
WO/2016/126423A2
Z is CR4R5, C=CR4R5 SiR4R5, GeR4R5 NR4a, PR4a, P(O)R4a, O, S, SO, SO2, Se; SeO, SeO2, Te, TeO, or TeO2; R1 - R3 are the same or different at each occurrence and are D, aryl, heteroaryl, alkyl, amino, silyl, germyl, deuterated aryl, deute...  
WO/2016/127111A1
A purified cannabidiol (CBD) extract and/or cannabidiolic acid (CBDA) extract is isolated from industrial hemp and comprises less than 0.5 wt % organic impurities as measured by HPLC and 1H NMR spectroscopy exhibits no detectable peak at...  
WO/2016/126152A1
A process for recovering tocotrienols/tocopherols from vegetable oil distillate comprising the steps of esterifying the vegetable oil distillate with an alcohol in the presence of an acid catalyst to convert the fatty acids contained the...  
WO/2016/121942A1
The purpose of the present invention is to provide a cationic lipid that can be used as a nucleic acid delivery carrier, a lipid membrane structure in which the cationic lipid is used, a nucleic-acid-introducing agent in which the cation...  
WO/2016/123244A1
This technology relates to fluorescein conjugates including fluorescein conjugates of polymers.  
WO/2016/118822A1
The invention provides compounds effective as inhibitors of monocarboxylate transporters such as MCT1 and MCT4, which can be used for treatment of medical conditions wherein treatment of the condition with a compound having an inhibitor ...  
WO/2016/115962A1
Provided is a preparation method for a Nebivolol intermediate of compounds of formula V, which comprises one of the methods as follows: (1) a RS/RR-IV compound and a compound of formula S-I are subjected to a coupling and docking reactio...  
WO/2016/115263A1
The present disclosure provides edible compositions comprising a sweet taste modulator or bitter taste blocker of the present disclosure, food products comprising such edible compositions and methods of preparing such food products. The ...  
WO/2016/115278A1
The present disclosure provides edible compositions comprising a flavor- grade sweet taste modulator or a combination of flavor-grade sweet taste modulators or a flavor-grade bitter taste blocker or a combination of flavor-grade bitter t...  
WO/2016/111347A1
Provided is a drug the active ingredient of which is a compound having antagonistic activity against EP4 receptor in the prevention and/or treatment of disease attributed to activation of EP4 receptor. The compound represented by general...  
WO/2016/106543A1
The present disclosure relates to a leveling compound for electrodepositing metals. The compound is of formula (I) or a salt thereof:  

Matches 701 - 750 out of 15,235